Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults

Journal of Alzheimer's Disease

Volumn 51, Issue 3, 2016, Pages 713-725

  Külzow, Nadine ^a   Witte, A Veronica ^b   Kerti, Lucia ^a   Grittner, Ulrike ^a   Schuchardt, Jan Philipp ^c   Hahn, Andreas ^c   Flöel, Agnes ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^c LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

Cognitive aging; dietary prevention; docosahexaenoic acid; eicosapentaenoic acid; fish oil

Indexed keywords

LONG CHAIN FATTY ACID; LONG CHAIN POLYUNSATURATED OMEGA 3 FATTY ACID; OMEGA 3 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG; APOLIPOPROTEIN E; NOOTROPIC AGENT;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM FUNCTION DISORDER; DOUBLE BLIND PROCEDURE; EPISODIC MEMORY; FEMALE; FLATULENCE; GASTROINTESTINAL SYMPTOM; GENOTYPE; HABIT; HEADACHE; HUMAN; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; OBJECT LOCATION MEMORY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REY AUDITORY VERBAL LEARNING TEST; SKIN IRRITATION; STATE TRAIT ANXIETY INVENTORY; TASK PERFORMANCE; TREATMENT DURATION; ADVERSE EFFECTS; BLOOD ANALYSIS; COGNITIVE AGING; DIETARY SUPPLEMENT; FEEDING BEHAVIOR; GENETICS; HEARING; LEARNING; MIDDLE AGED; TREATMENT OUTCOME;

AGED; APOLIPOPROTEINS E; AUDITORY PERCEPTION; BLOOD CHEMICAL ANALYSIS; COGNITIVE AGING; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEEDING BEHAVIOR; FEMALE; HUMANS; LEARNING; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; TREATMENT OUTCOME;

EID: 84963749096     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150886     Document Type: Article

References (59)

1. Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7, 137-152.
2. Morris JC (2005) Mild cognitive impairment and preclinical Alzheimer's disease. Geriatrics Suppl, 9-14.
3. Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, Salem N Jr, Stedman M (2010) Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 6, 456-464.
4. Hashimoto M, Hossain S (2011) Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: Beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease. J Pharmacol Sci 116, 150-162.
5. Stonehouse W (2014) Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy schoolaged children and throughout adulthood? Evidence from clinical trials. Nutrients 6, 2730-2758.
6. Huhn S, Kharabian Masouleh S, Stumvoll M, Villringer A, Witte AV (2015) Components of a Mediterranean diet and their impact on cognitive functions in aging. Front Aging Neurosci 7, 132.
7. Arterburn LM, Hall EB, Oken H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83, 1467S-1476S.
8. Luchtman DW, Song C (2013) Cognitive enhancement by omega-3 fatty acids from child-hood to old age: Findings from animal and clinical studies. Neuropharmacology 64, 550-565.
9. Su HM (2010) Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. J Nutr Biochem 21, 364-373.
10. Denis I, Potier B, Vancassel S, Heberden C, Lavialle M (2013) Omega-3 fatty acids and brain resistance to ageing and stress: Body of evidence and possible mechanisms. Ageing Res Rev 12, 579-594.
11. Boudrault C, Bazinet RP, Ma DW (2009) Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. J Nutr Biochem 20, 1-10.
12. Billard JM (2006) Ageing, hippocampal synaptic activity and magnesium. Magnes Res 19, 199-215.
13. Tanabe Y, Hashimoto M, Sugioka K, Maruyama M, Fujii Y, Hagiwara R, Hara T, Hossain SM, Shido O (2004) Improvement of spatial cognition with dietary docosahexaenoic acid is associated with an increase in Fos expression in rat CA1 hippocampus. Clin Exp Pharmacol Physiol 31, 700-703.
14. Gamoh S, Hashimoto M, Hossain S, Masumura S (2001) Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats. Clin Exp Pharmacol Physiol 28, 266-270.
15. Yurko-Mauro K, Alexander DD, Van Elswyk ME (2015) Docosahexaenoic acid and adult memory: A systematic review and meta-analysis. PLoS One 10, e0120391.
16. Sydenham E, Dangour AD, Lim WS (2012) Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev 6, CD005379.
17. Nilsson A, Radeborg K, Salo I, Bjorck I (2012) Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects:Arandomized controlled cross-over study. Nutr J 11, 99.
18. Mazereeuw G, Lanctot KL, Chau SA, Swardfager W, Herrmann N (2012) Effects of omega-3 fatty acids on cognitive performance: A meta-analysis. Neurobiol Aging 33, 1482 e1417-1429.
19. Jiao J, Li Q, Chu J, ZengW, Yang M, Zhu S (2014) Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age:Asystematic review and meta-analysis of randomized controlled trials.AmJ Clin Nutr 100, 1422-1436.
20. van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, Olderikkert MG, Beekman AT, de Groot CP (2008) Effect of fish oil on cognitive performance in older subjects: A randomized, controlled trial. Neurology 71, 430-438.
21. Stough C, Downey L, Silber B, Lloyd J, Kure C, Wesnes K, Camfield D (2012) The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population. Neurobiol Aging 33, 824 e821-823.
22. Dangour AD, Allen E, Elbourne D, Fasey N, Fletcher AE, Hardy P, Holder GE, Knight R, Letley L, Richards M, Uauy R (2010) Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: Arandomized, double-blind, controlled trial.AmJ Clin Nutr 91, 1725-1732.
23. Witte AV, Kerti L, Hermannstadter HM, Fiebach JB, Schreiber SJ, Schuchardt JP, Hahn A, Floel A (2014) Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex 24, 3059-3068.
24. Sinn N, Milte CM, Street SJ, Buckley JD, Coates AM, Petkov J, Howe PR (2012) Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: A 6-month randomised controlled trial. Br J Nutr 107, 1682-1693.
25. Lee LK, Shahar S, Chin AV, Yusoff NA (2013) Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): A 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology (Berl) 225, 605-612.
26. Danthiir V, Hosking D, Burns NR, Wilson C, Nettelbeck T, Calvaresi E, Clifton P, Wittert GA (2014) Cognitive performance in older adults is inversely associated with fish consumption but not erythrocyte membrane n-3 fatty acids. J Nutr 144, 311-320.
27. Kulzow N, Kerti L, Witte VA, Kopp U, Breitenstein C, Floel A (2014) An object location memory paradigm for older adults with and without mild cognitive impairment. J Neurosci Methods 237, 16-25.
28. Floel A, Suttorp W, Kohl O, Kurten J, Lohmann H, Breitenstein C, Knecht S (2012) Non-invasive brain stimulation improves object-location learning in the elderly. Neurobiol Aging 33, 1682-1689.
29. Postma A, Kessels RP, van AsselenM(2008) How the brain remembers and forgets where things are: The neurocognition of object-location memory. Neurosci Biobehav Rev 32, 1339-1345.
30. Vacante M,Wilcock GK, de JagerCA(2013) Computerized adaptation of The Placing Test for early detection of both mild cognitive impairment and Alzheimer's disease. J Clin Exp Neuropsychol 35, 846-856.
31. Troyer AK, Murphy KJ, Anderson ND, Hayman-Abello BA, Craik FI, Moscovitch M (2008) Item and associative memory in amnestic mild cognitive impairment: Performance on standardized memory tests. Neuropsychology 22, 10-16.
32. Petrella JR, Prince SE, Wang L, Hellegers C, Doraiswamy PM (2007) Prognostic value of posteromedial cortex deactivation in mild cognitive impairment. PLoS One 2, e1104.
33. Bucks RS,Willison JR (1997) Development and validation of the Location Learning Test (LLT): A test of visuo-spatial learning designed for use with older adults and in dementia. Clin Neuropsychol 11, 273-286.
34. Folstein MF, Folstein SE, McHugh PR (1975) "Minimental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
35. Hautzinger M, Bailer M, Worall H, Keller F (2001) Beck-Depressions-Inventar (BDI). Testhandbuch, Hans Huber, Bern.
36. Laux L, Glanzmann P, Schaffner P, Spielberger C (1981) Das State-Trait-Angst Inventar. Theoretische Grundlagen und Handanweisung, Beltz Test GmbH, Weinheim.
37. Helmstaedter C, Lendt M, Lux S (2001) Verbaler Lern-und Merkfähigkeitstest (VLMT), Beltz, Göttingen.
38. Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol 54, 1063-1070.
39. von Schacky C, Harris WS (2007) Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res 73, 310-315.
40. Kerti L, Witte AV, Winkler A, Grittner U, Rujescu D, Floel A (2013) Higher glucose levels associated with lower memory and reduced hippocampal microstructure. Neurology 81, 1746-1752.
41. Frey I, Berg A, Grathwohl D, Keul J (1999) [Freiburg Questionnaire of physical activity-development, evaluation and application]. Soz Praventivmed 44, 55-64.
42. Floel A, Witte AV, Lohmann H, Wersching H, Ringelstein EB, Berger K, Knecht S (2008) Lifestyle and memory in the elderly. Neuroepidemiology 31, 39-47.
43. Danthiir V, Burns NR, Nettelbeck T, Wilson C, Wittert G (2011) The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: A randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults. Nutr 10, 117.
44. von Schacky C (2007) Omega-3 fatty acids and cardiovascular disease. Curr Opin Clin Nutr Metab Care 10, 129-135.
45. Johnson EJ, McDonald K, Caldarella SM, Chung HY, Troen AM, Snodderly DM (2008) Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr Neurosci 11, 75-83.
46. Delis DC, Kramer J, Kaplan E, Ober B (1987) California Verbal Learning Test: Adult Version, Psychological Corporation, New York.
47. Wesnes KA,Ward T, Ayre G, Pincock C (1999) Validity and utility of the cognitive drug research (CDR) computerised cognitive testing system: A review following fifteen years of usage. Eur Neuropsychopharmacol 9, 368.
48. Richter Y, Herzog Y, Cohen T, Steinhart Y (2010) The effect of phosphatidylserine-containing omega-3 fatty acids on memory abilities in subjects with subjective memory complaints: A pilot study. Clin Interv Aging 5, 313-316.
49. Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD (2010) Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: A double-blind placebocontrolled trial. Dement Geriatr Cogn Disord 29, 467-474.
50. Kotani S, Sakaguchi E,Warashina S, Matsukawa N, Ishikura Y, KisoY, Sakakibara M,Yoshimoto T, Guo J,Yamashima T (2006) Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res 56, 159-164.
51. Iachini I, Iavarone A, Senese VP, Ruotolo F, Ruggiero G (2009) Visuospatial memory in healthy elderly, AD and MCI: A review. Curr Aging Sci 2, 43-59.
52. Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L (2005) Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 35, 691-699.
53. Kawakita E, Hashimoto M, Shido O (2006) Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 139, 991-997.
54. He C, Qu X, Cui L,Wang J, Kang JX (2009) Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc Natl Acad Sci U S A 106, 11370-11375.
55. Fujita S, Ikegaya Y, Nishikawa M, Nishiyama N, Matsuki N (2001) Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A(2) inhibitor in rat hippocampal slices. Br J Pharmacol 132, 1417-1422.
56. Wu A, Ying Z, Gomez-Pinilla F (2004) Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma 21, 1457-1467.
57. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF,Meyer-Lindenberg A, Weinberger DR (2004) The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24, 10099-10102.
58. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269.
59. Weber P, RaederstorffD(2000)Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids-A review. Nutr Metab Cardiovasc Dis 10, 28-37.